Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydroisoquinoline derivatives as LHRH antagonists

Tetrahydroisoquinoline derivatives as LHRH antagonists

US Patent 5981521 · Granted Nov 9, 1999

Estimated economic value: $58,994,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benz2023
Anti-c-Met antibody drug conjugates2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benz2021
Method for functionalizing carbon nanoparticles and compositions2021
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2020
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Process for making modulators of cystic fibrosis transmembrane conductance regul2017
Sphingosine 1-phosphate receptor antagonists2017